A Novel Mouse Model of Liver Ischemic/Reperfusion Injury and its Differences to the Existing Model

Jianjian Zhang1, Ming Zhang1, Jianjun Zhang1

  • 1a Department of Transplantation and Hepatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University , Shanghai , China.

Abstract

Insights

A new 35% liver ischemia/reperfusion (I/R) model offers improved reproducibility over the existing 70% model. This novel approach ensures stable hypoxia for more reliable experimental outcomes in hepatic I/R studies.

Area of Science:

  • Hepatology
  • Surgical Innovation
  • Experimental Models

Background:

  • The established 70% mouse hepatic ischemia/reperfusion (I/R) model, involving cephalad lobe ischemia without outflow occlusion, exhibits significant result variability.
  • This variability is attributed to incomplete blood expulsion and potential vena cava reflux, hindering stable hypoxic conditions.

Purpose of the Study:

  • To develop and validate a novel, more reproducible mouse model for hepatic ischemia/reperfusion (I/R) injury.
  • To compare the reproducibility and stability of a new 35% liver mass I/R model against the existing 70% model.

Main Methods:

  • A novel 35% liver mass I/R model was created by occluding inflow and outflow to the left lateral lobe.
  • The existing 70% model (cephalad lobe ischemia) was used for comparison.
  • Biochemical, histological, and tissue oxygen partial pressure (tPO2) analyses were conducted on both models.

Main Results:

  • The 35% I/R model demonstrated significantly lower coefficients of variation (CV) in aminotransferase activities, histological scores, and tPO2 levels compared to the 70% model.
  • tPO2 measurements confirmed that the 70% model failed to achieve stable hypoxia due to blood reflux, unlike the 35% model.

Conclusions:

  • The novel 35% hepatic I/R model provides more reproducible results due to complete occlusion of both inflow and outflow.
  • This enhanced model facilitates stable hypoxic conditions, reducing experimental variance in hepatic I/R research.

Related Concept Videos